FOLFOX4 in advanced colorectal cancer: A monoinstitutional experience

Giorgia Boscolo, Lara Maria Pasetto, Antonio Jirillo, Silvio Monfardini

Research output: Contribution to journalArticle


Aims and background: Patients included in clinical trials are "selected", and they usually differ from those commonly treated. Methods: From 1999 to 2004, in the Medical Oncology Department of Padua (Italy), 70 metastatic colorectal cancers were treated with FOLFOX4. Results: Our results, compared with those of the registration trial (response rate, duration of response and progression-free survival) appeared lower; overall survival was improved. Conclusions: The number of therapeutic regimens more than their type influenced the results.

Original languageEnglish
Pages (from-to)193-196
Number of pages4
Issue number3
Publication statusPublished - May 2006


  • Chemotherapy
  • Colorectal cancer
  • Metastases
  • Review

ASJC Scopus subject areas

  • Cancer Research

Fingerprint Dive into the research topics of 'FOLFOX4 in advanced colorectal cancer: A monoinstitutional experience'. Together they form a unique fingerprint.

  • Cite this

    Boscolo, G., Pasetto, L. M., Jirillo, A., & Monfardini, S. (2006). FOLFOX4 in advanced colorectal cancer: A monoinstitutional experience. Tumori, 92(3), 193-196.